Unwanted Side Reactions as a Relevant Problem of Fundamental and Clinical Pharmacology
https://doi.org/10.33647/2074-5982-16-3-115-119
Abstract
The article is devoted to a topical issue in pharmacology, i.e. undesirable side reactions. Modern ideas about the possible causes of their occurrence and prevalence in the world are presented. The main problems and corresponding tasks of developing the pharmacovigilance system in Russia are outlined.
About the Authors
T. S. Litvinenko
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Tatyana S. Litvinenko
344022, Rostov-on-Don, Nakhichevansky lane, 29
A. V. Safronenko
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Andrey V. Safronenko, Dr. Sci. (Med.), Assoc. Prof.
344022, Rostov-on-Don, Nakhichevansky lane, 29
E. V. Gantsgorn
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Elena V. Gantsgorn, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky lane, 29
L. I. Dyatchina
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Lyudmila I. Dyatchina, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky lane, 29
I. V. Zamlelaya
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Irina V. Zamlelaya, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky lane, 29
I. M. Myakota
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Irina M. Myakota, Cand. Sci. (Med.)
344022, Rostov-on-Don, Nakhichevansky lane, 29
V. O. Bystrovsky
Rostov State Medical University of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Vladimir O. Bystrovsky
344022, Rostov-on-Don, Nakhichevansky lane, 29
References
1. Glagolev S.V., Gorelov K.V., Chizhova D.A. Razvitie sistemy farmakonadzora v Rossijskoj Federacii [Development of the pharmacovigilance system in the Russian Federation]. Vestnik Roszdravnadzora [Bulletin of Roszdravnadzor]. 2019;(2):72–77. (In Russian).
2. Zhuravleva M.V., Romanov B.K., Gorodeckaya G.I., Muslimova O.V., Krysanova V.S., Demchenkova E. Yu. Aktual’nye voprosy bezopasnosti lekarstvennyh sredstv, vozmozhnosti sovershenstvovaniya sistemy farmakonadzora [Topical issues of drug safety, possibilities of improving of pharmacovigilance]. Bezopasnost’ i risk farmakoterapii [Safety and Risk of Pharmacotherapy]. 2019;7(3):109–119. (In Russian). DOI: 10.30895/2312-7821-2019-7-3-109-119.
3. Hoseva E.N., Morozova T.E., Ermakov D.A., Oshorova S.D. Voprosy kontrolya bezopasnosti lekarstvennoj terapii v shirokoj klinicheskoj praktike: pozicii pacientov i medrabotnikov [The issues of monitoring the safety of drug therapy in clinical practice: positions of patients and medical workers]. Vrach-aspirant [The Doctor Post-Graduate Student]. 2013;2.1(57):203–212. (In Russian).
4. Shubnikova E.V., Darmostukova M.A., Bukatina T.M., Kaperko D.A., Vel’ts N.Yu., Kazakov A.S., et al. O zaregistrirovannyh v postmarketingovyj period nezhelatel’nyh reakciyah lekarstvennyh sredstv [The adverse drug reactions registered during the postmarketing period]. Bezopasnost’ i risk farmakoterapii [Safety and Risk of Pharmacotherapy]. 2019;7(1):15–22. (In Russian). DOI: 10.30895/2312-7821-2019-7-1-15-2.
5. Ahern F., Sahm L.J., Lynch D., McCarthy S. Determining the frequency and preventability of adverse drug reaction related admissions to an Irish University Hospital: a cross sectional study. Emerg. Med. J. 2014;31:24–29.
6. Akbari Sari A., Doshmangir L., Torabi F., Rashidian A., Sedaghat M., Ghomi R. The incidence, nature and consequences of adverse events in Iranian hospitals. Arch. Iran. Med. 2015;18:811–815.
7. Bénard Laribière A., Miremont Salamé G., Pérault Pochat M.C., Noize P., Haramburu F. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam. Clin. Pharmacol. 2015;29:106–111.
8. http://www.who.int/medicines/areas/rational_use/ru
9. Leendertse A.J., Visser D., Egberts A.C.G., van den Bemt P.M.L.A. The relationship between study characteristics and the prevalence of medication related hospitalizations: a literature review and novel analysis. Drug. Saf. 2010;33:233–244.
10. Pedrós C., Quintana B., Rebolledo M., Porta N., Vallano A., Arnau J.M. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur. J. Clin. Pharmacol. 2014;70:361–367.
Review
For citations:
Litvinenko T.S., Safronenko A.V., Gantsgorn E.V., Dyatchina L.I., Zamlelaya I.V., Myakota I.M., Bystrovsky V.O. Unwanted Side Reactions as a Relevant Problem of Fundamental and Clinical Pharmacology. Journal Biomed. 2020;16(3):115-119. (In Russ.) https://doi.org/10.33647/2074-5982-16-3-115-119
Views:
612
Email this article 
